ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)
Launched by BAXALTA NOW PART OF SHIRE · Mar 4, 2014
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participant has hemophilia A {FVIII lesser than or equal to (\<=)5%}
- • Participant is prescribed Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method (rAHF-PFM) or Antihemophilic Factor (Recombinant) - Pegylated (rAHF-PEG) by the treating physician
- • Participant or participant's legally authorized representative provides informed consent
- Exclusion Criteria:
- • Participant has known hypersensitivity to the active substance or any of the excipients
- • Participant has known allergic reaction to mouse or hamster proteins
- • Participant has participated in another clinical study involving an investigational product (IP) or device within 30 days prior to study enrollment or is scheduled to participate in another clinical study involving another FVIII concentrate or device during the course of this study
About Baxalta Now Part Of Shire
Baxalta, now part of Shire, is a global biopharmaceutical company dedicated to developing innovative therapies for rare and complex diseases. With a strong emphasis on patient-centric solutions, Baxalta leverages cutting-edge science and advanced technologies to address unmet medical needs, particularly in hematology, immunology, and oncology. The company is committed to advancing clinical research and fostering collaborations that enhance treatment options and improve quality of life for patients worldwide. As part of Shire, Baxalta continues to build on a legacy of excellence in biopharmaceutical development, driving forward the next generation of therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ottawa, Ontario, Canada
Copenhagen, , Denmark
Lausanne, , Switzerland
Saskatoon, Saskatchewan, Canada
Camperdown, New South Wales, Australia
Gdansk, , Poland
St. Gallen, , Switzerland
Bern, , Switzerland
Zürich, , Switzerland
Paris, , France
Stockholm, , Sweden
Le Chesnay Cedex, , France
Torino, , Italy
Milano, , Italy
Napoli, , Italy
Wien, , Austria
Zürich, , Switzerland
Roma, , Italy
Toronto, Ontario, Canada
Roma, , Italy
Toronto, Ontario, Canada
Macerata, , Italy
Bologna, , Italy
Basel, , Switzerland
London, , United Kingdom
Oslo, , Norway
Edmonton, Alberta, Canada
Murdoch, Western Australia, Australia
Linz, , Austria
Linz, , Austria
Bruxelles, , Belgium
Fortaleza, Ceará, Brazil
Vitória, Espírito Santo, Brazil
Curitiba, Paraná, Brazil
Porto Alegre, Parthenon, Brazil
Belém, Pará, Brazil
Campinas, São Paulo, Brazil
Ribeirão Preto, São Paulo, Brazil
Rio De Janeiro, , Brazil
São Paulo, , Brazil
Moncton, New Brunswick, Canada
Shenzhen, Futian, China
Guangzhou, Guangdong, China
Tianjin, Heping, China
Wuhan, Hubei, China
Xuzhou, Jiangsu, China
Jinan, Shandong, China
Beijing, , China
Nanjing, , China
Shenzhen, , China
Atlantico, , Colombia
Bogotá, , Colombia
Floridablanca, , Colombia
Brno, , Czechia
Ostrava, , Czechia
Ostrava, , Czechia
Praha 5, , Czechia
Brest, , France
Caen Cedex, , France
Chambery Cedex, , France
Dijon Cedex, , France
Limoges Cedex, , France
Nantes Cedex, , France
Reims Cedex, , France
Rennes Cedex 09, , France
Rouen, , France
Saint Priest En Jarez, , France
Toulouse Cedex 9, , France
Goudi, Athens, Greece
Goudi, Athens, Greece
Thessaloniki, , Greece
Budapest, , Hungary
Debrecen, , Hungary
Mohács, , Hungary
Nyíregyháza, , Hungary
Szombathely, , Hungary
Bari, , Italy
Catania, , Italy
Catanzaro, , Italy
Firenze, , Italy
Padova, , Italy
Palermo, , Italy
Reggio Calabria, , Italy
Roma, , Italy
Scorrano, , Italy
Oslo, , Norway
Bydgoszcz, , Poland
Warszawa, , Poland
Wroclaw, , Poland
Ponta Delgada, Açores, Portugal
Coimbra, , Portugal
Lisboa, , Portugal
Porto, , Portugal
Chelyabinsk, , Russian Federation
Moscow, , Russian Federation
Petrozavodsk, , Russian Federation
Saint Petersburg, , Russian Federation
Samara, , Russian Federation
Ljubljana, , Slovenia
A Coruña, , Spain
Barcelona, , Spain
Barcelona, , Spain
Palma De Mallorca, , Spain
Gothenburg, , Sweden
Malmö, , Sweden
Luzern 17, , Switzerland
Wabern, , Switzerland
Zürich, , Switzerland
Basingstoke, Hampshire, United Kingdom
Cambridge, , United Kingdom
Canterbury, , United Kingdom
Patients applied
Trial Officials
Study Director
Study Director
Takeda
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials